Abstract
Tumour hypoxia is a major obstacle in cancer therapy that leads to poor prognosis. Therefore, the development of cancer treatments that are effective in hypoxia is necessary. Nitrogen-containing bisphosphonates (N-BPs), which are used to treat bone disease, are cytotoxic to several cancer cells in normoxia. Therefore, we investigated the cytotoxicity of N-BPs in cancer cells in hypoxia. We studied the cytotoxicities of N-BPs, statins and anticancer drugs in human cancer cells under hypoxic conditions (1% O2 ). The expression levels of enzymes in the mevalonate pathway in hypoxia were measured by real-time reverse transcription polymerase chain reaction and Western blotting. In hypoxia, cell growth inhibition by 5-fluorouracil and cisplatin was not changed as compared to that in normoxia; however, cell growth inhibition by N-BPs and via zoledronate-induced apoptosis was higher in hypoxia than that in normoxia. Furthermore, geranylgeraniol completely inhibited the growth inhibitory effects of zoledronate. Additionally, the mRNA and protein levels of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase significantly decreased in hypoxia. Moreover, simvastatin potentiated the growth inhibitory effect of zoledronate. The cytoto...Continue Reading
References
Jan 15, 1992·Cancer·Y ShimadaT Tobe
Aug 28, 1997·Biochemical and Biophysical Research Communications·D C CrickC J Waechter
Oct 21, 1999·Biochemical and Biophysical Research Communications·E van BeekS Papapoulos
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Jun 26, 2002·Biological & Pharmaceutical Bulletin·Kohji TakaraKatsuhiko Okumura
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
May 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rey-Ting GuoAndrew H-J Wang
Jul 20, 2007·The Journal of Biological Chemistry·Andrew D NguyenRussell A DeBose-Boyd
May 26, 2009·Biochemical Pharmacology·Antonello A RomaniPaolo Soliani
Sep 5, 2009·Cancer Chemotherapy and Pharmacology·Rhys D ClyburnIngunn Holen
Jan 6, 2012·BMC Cancer·Sophie DoublierAnna Sapino
May 9, 2013·Biochimica Et Biophysica Acta·Nan WuKarmin O
Jan 1, 2011·Cancers·Shaojuan Li, Paul De Souza
Jul 30, 2014·PloS One·Sung Hoon ChoiKwang-Hyub Han
Nov 14, 2014·Cell Death & Disease·S OkamotoM Tagawa
Mar 31, 2015·FEBS Letters·Wei-Bo ChenBin Xue
Apr 22, 2015·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·T MinegakiK Nishiguchi
Oct 13, 2015·Dermatology : International Journal for Clinical and Investigative Dermatology·Julia LengfeldMarion Wobser
Jan 11, 2016·Cancer Medicine·Vasilios LiapisAndreas Evdokiou
May 18, 2016·Biological & Pharmaceutical Bulletin·Mahitab ElsayedTakao Shimazoe
Oct 19, 2016·Digestive Diseases and Sciences·Marcin MagierowskiTomasz Brzozowski
Apr 19, 2017·The Journal of Biological Chemistry·Seonghwan HwangRussell A DeBose-Boyd